Centessa Pharmaceuticals PLC
CNTAHealthcare|Biotechnology|UK
$40.50
+0.00 (+0.00%)
Tangible Book
$3.15
Earnings Power
$1.77
Upcoming Data Readouts (3)
Dec 2026
Est. completion
P2Narcolepsy Type 1
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
NCT06752668n=248
Jun 2027
Est. completion
P1Healthy Adult Male and Female Volunteers
A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years
NCT07413666n=212
Sep 2027
Est. completion
P2P3Narcolepsy Type 1
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
NCT07598708n=222